INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 900 | $9.44 | 10,317 |
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $9.45 | 10,217 |
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 1,200 | $9.48 | 9,017 |
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 1,300 | $9.49 | 7,717 |
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 300 | $9.50 | 7,417 |
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $9.53 | 7,317 |
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 500 | $9.54 | 6,817 |
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $9.55 | 6,717 |
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 200 | $9.56 | 6,517 |
| Aug 05, 2005 |
SVP, PreclinDevel & Biomol Sci
Trans History: 660
|
SVP, PreclinDevel & Biomol Sci | Form 4 | Open market or private sale of non-derivative or derivative security | 1,146 | $9.57 | 5,371 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.